Tuesday, 15 Oct 2019

You are here

Dr. Olga Petryna - Canakinumab in CVD Pts Prevents Acute Gout Attacks

Dr. Petryna reviews Dr. Dan Solomon's EULAR 2018 plenary presentation showing a 50-60% reduction in acute gout amongst CVD patients treated with canakinumab.

Add new comment

Want to talk about this video? Comment here to lead the discussion.
MORE VIDEOS

Dr. Orrin Troum and Dr. Alvin Wells: OA...

09 Feb 2018

Dr. Jack Cush at EULAR 2018 - DECT...

14 Jun 2018

RheumNow Podcast - Scurvy and Mechanics...

01 Feb 2019

Dr. Olga Petryna: Role of TNFi on anti-...

16 Nov 2016

Dr. Len Calabrese - Wine & the...

13 Nov 2016

Dr. Cassie Calabrese: Checkpoint...

25 Oct 2018

The RheumNow Week in Review – 9 June...

09 Jun 2017

8 September 2017: The RheumNow Week in...

07 Sep 2017

Dr. Julio Gonzalez: Radiographic...

08 Nov 2017

Dr. George Martin: New Molecular...

11 Feb 2018

Dr. Ronan Kavanagh: The greatest...

14 Nov 2016

Dr. Kristal Choi: Developing a...

11 Feb 2018